Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA
-
Upload
ann-meredith-garcia -
Category
Health & Medicine
-
view
114 -
download
1
Transcript of Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA
![Page 1: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/1.jpg)
Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CAAnn Meredith U. Garcia, MD
![Page 2: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/2.jpg)
Background• About 30% of all patients treated with curative intent will
eventually develop distant metastases.• Adjuvant chemotherapy might prevent distant metastases
by eliminating CTCs and micrometastases.• A clear benefit of adjuvant chemotherapy has been shown
for patients with stage III colon CA.• Levamisole and fluorouracil • Capecitabine• FOLFOX – (MOSAIC) trial
![Page 3: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/3.jpg)
Background• For patients treated without preoperative (chemo)RT and
TME surgery, which results in high numbers of locoregional recurrences, adjuvant chemotherapy is effective.
• However, the use of adjuvant chemotherapy for patients with rectal CA treated with preoperative (chemo)RT and surgery is debated.
![Page 4: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/4.jpg)
![Page 5: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/5.jpg)
Search strategy & selection criteria• Published and unpublished European randomized,
controlled, phase 3 trials comparing observation with adjuvant chemotherapy after preoperative (chemo)RT and surgery for patients with non-metastatic rectal CA
• PubMed, Medline (OVID version), Embase (OVID version), Web of Science, the Cochrane Library, and CENTRAL
• Abstracts from the most important international meetings (ECCO, ESTRO, ESSO, and ESMO)
• Individual patient data for baseline characteristics, tumor characteristics, preoperative treatment, surgery, adjuvant treatment, and follow-up
![Page 6: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/6.jpg)
![Page 7: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/7.jpg)
Outcomes• Primary endpoint: Overall survival• Secondary endpoints:
• Disease-free survival• Distant recurrences
![Page 8: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/8.jpg)
Study characteristicsFU+FA FU+FA; Cape FU+FA CapeOx
![Page 9: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/9.jpg)
Patientcharacteristics
![Page 10: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/10.jpg)
Overall survival
![Page 11: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/11.jpg)
Disease-free survival
![Page 12: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/12.jpg)
Distant recurrence
![Page 13: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/13.jpg)
Distant recurrence
![Page 14: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/14.jpg)
Conclusions• Fluorouracil-based adjuvant chemotherapy has no
benefit on overall survival, disease-free survival, and distant recurrences after a median follow-up of 7 years in patients with:• (y)pTNM stage II or III rectal CA• R0 resection• LAR or APR• Tumor located within 15 cm of the anal verge
• Adjuvant chemotherapy might improve disease-free survival and distant recurrences in patients with a tumor located 10–15 cm from the anal verge.
![Page 15: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/15.jpg)
Limitations• Low adherence to treatment • Changes in practice over time• QUASAR trial excluded due to lack of individual patient
data
![Page 16: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/16.jpg)
![Page 17: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/17.jpg)
655 patients (cT3-4, Nx) treated with
chemoRT + SxFU+FA x 6 cycles
(N = 324)
Follow-up(N = 310)
RA
ND
OM
IZA
TIO
N
Median follow-up: 63.7 months
![Page 18: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/18.jpg)
![Page 19: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/19.jpg)
![Page 20: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/20.jpg)
![Page 21: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/21.jpg)
![Page 22: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/22.jpg)
470 patients (stage II or III) treated with
(chemo)RT + TME FU+FA x 6-12 cycles
(N = 216)
Surveillance(N = 221)
RA
ND
OM
IZA
TIO
N
Median follow-up: 5 years
*840 patients
![Page 23: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/23.jpg)
![Page 24: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/24.jpg)
79.2% vs. 80.4%HR 0.93, 95% CI 0.62‐1.39; p=0.73
55.4% vs. 62.7%HR 0.80, 95% CI 0.60‐1.07; p=0.13
![Page 25: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/25.jpg)
![Page 26: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/26.jpg)
1,011 patients (cT3-4)
Preop RT surveillance(N = 252)
RA
ND
OM
IZA
TIO
N
Median follow-up: 10.4 years
Preop chemoRT surveillance(N = 253)
Preop RT adjuvant chemo(N = 253)
Preop chemoRT adjuvant chemo(N = 253)
![Page 27: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/27.jpg)
![Page 28: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/28.jpg)
51.8% vs. 48.4%HR 0·91, 95% CI 0·77–1·09; p=0·32
![Page 29: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/29.jpg)
47.0% vs. 43.7%HR 0·91, 95% CI 0·77–1·08; p=0·29
![Page 30: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/30.jpg)
![Page 31: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/31.jpg)
113 patients (stage II or III) treated with chemoRT +
TME CapeOx x 6 cycles (N = 54)
Observation(N = 59)
RA
ND
OM
IZA
TIO
N
Median follow-up: 44.8 months
*800 patients
![Page 32: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/32.jpg)
![Page 33: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/33.jpg)
71.3% vs. 77.5%0.80 (95% CI: 0.38-1.69; p=0.56
87.8% vs. 88.8%1.18 (95% CI: 0.43-3.26; p=0.75
![Page 34: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/34.jpg)
![Page 35: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/35.jpg)
![Page 36: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/36.jpg)
![Page 37: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/37.jpg)
![Page 38: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/38.jpg)
![Page 39: Benefit of adjuvant chemotherapy after preoperative chemoRT + surgery in rectal CA](https://reader030.fdocuments.net/reader030/viewer/2022032513/55d36cedbb61ebff018b4588/html5/thumbnails/39.jpg)